# Enhancing drug administration in Drosophila melanogaster: a method for using solid dispersions for improved solubility and bioavailability

**Authors:** Sunayn Cheku, Blase Rokusek, Mahesh Pattabiraman, Kimberly A. Carlson

PMC · DOI: 10.1080/19336934.2025.2497565 · Fly · 2025-04-25

## TL;DR

This paper introduces a new method to improve drug delivery in fruit flies by using solid dispersions to increase solubility and effectiveness of hydrophobic compounds.

## Contribution

A novel method for administering hydrophobic compounds to Drosophila using PEG-based solid dispersions is introduced.

## Key findings

- PEG-based solid dispersions increase the aqueous solubility of hydrophobic compounds like RU486.
- Subcutaneous injections, CAFE assay, and mixing with solid food are effective methods for administering the dispersions.
- PEG-RU486 showed enhanced bioavailability compared to RU486 dissolved in ethanol.

## Abstract

Drosophila melanogaster is a widely used model organism for diseases such as Parkinson’s disease, Alzheimer’s disease, obesity, and diabetes. However, compound administration-based toxicological and behavioural studies on Drosophila have been hindered by technical difficulties associated with inefficient administration of hydrophobic compounds. This study illustrates a general method to make and distribute PEG 8000–based solid dispersions for three hydrophobic compounds, distearoylglycerol (DSG) geldanamycin (GA) and RU486 to D. melanogaster. The solid dispersions were validated, in vitro, using nuclear magnetic resonance spectroscopy (NMR), to have a higher aqueous solubility. The study also describes three different methods to administer the solid dispersions: subcutaneous injections, mixing in solid food, and the capillary feeder assay (CAFE). We show that the presence of 1% DMSO decreases survival, whereas PEG does not have an adverse effect. Lastly, we showed that the prepared PEG-RU486 formulation showed signs of enhanced bioavailability when compared to RU486 dissolved in ethanol. The methodology described in the study provides an easy and effective means to administer hydrophobic compounds to D. melanogaster using subcutaneous injections, CAFE assay, or by mixing it with solid food.

## Linked entities

- **Chemicals:** geldanamycin (PubChem CID 5288382), RU486 (PubChem CID 55245), PEG 8000 (PubChem CID 174), DMSO (PubChem CID 679), ethanol (PubChem CID 702)
- **Diseases:** Parkinson’s disease (MONDO:0005180), Alzheimer’s disease (MONDO:0004975), obesity (MONDO:0011122), diabetes (MONDO:0005015)
- **Species:** Drosophila melanogaster (taxon 7227)

## Full-text entities

- **Diseases:** obesity (MESH:D009765), diabetes (MESH:D003920), Alzheimer's disease (MESH:D000544), Parkinson's disease (MESH:D010300)
- **Chemicals:** RU486 (MESH:D015735), PEG (MESH:C000595216), ethanol (MESH:D000431), DMSO (MESH:D004121), GA (MESH:C001277), DSG (-)
- **Species:** Drosophila melanogaster (fruit fly, species) [taxon 7227]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12036485/full.md

## Figures

16 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12036485/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12036485/full.md

---
Source: https://tomesphere.com/paper/PMC12036485